Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M--Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M--ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XLV

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
XLVLeon Cooperman 2015-06-30 Sold Out -0.42%$71.46 - $76.45
($73.85)
$ 71.80-3%Sold Out0
XLVKen Fisher 2015-06-30 Add$71.71 - $76.45
($74.07)
$ 71.80-3%Add 5.40%271,515
XLVLeon Cooperman 2015-03-31 Buy 0.42%$67.86 - $74.9
($71.15)
$ 71.801%New holding366,000
XLVKen Fisher 2015-03-31 Add$68.05 - $74.9
($71.32)
$ 71.801%Add 4.15%257,614
XLVKen Fisher 2014-06-30 Add0.01%$55.71 - $61.23
($58.7)
$ 71.8022%Add 34.36%226,412
XLVGeorge Soros 2012-09-30 Sold Out -0.03%$37.27 - $40.3
($38.73)
$ 71.8085%Sold Out0
XLVGeorge Soros 2012-06-30 Buy 0.03%$35.52 - $37.87
($36.91)
$ 71.8095%New holding50,000
XLVKen Fisher 2012-06-30 Add$35.52 - $37.87
($36.91)
$ 71.8095%Add 53.52%119,754
XLVKen Fisher 2011-06-30 Buy 0.01%$33.28 - $36.42
($34.99)
$ 71.80105%New holding86,997
XLVGeorge Soros 2011-03-31 Sold Out $31.5 - $33.18
($32.33)
$ 71.80122%Sold Out0
XLVGeorge Soros 2010-12-31 Reduce-0.15%$30.19 - $31.78
($31.13)
$ 71.80131%Reduce 93.88%34,153
XLVGeorge Soros 2010-09-30 Buy 0.25%$28.03 - $30.68
($29.2)
$ 71.80146%New holding558,053
XLVGeorge Soros 2010-06-30 Sold Out $28.38 - $32.31
($30.13)
$ 71.80138%Sold Out0
XLVGeorge Soros 2010-03-31 Reduce$30.68 - $33
($31.72)
$ 71.80126%Reduce 43.59%6,600
XLVGeorge Soros 2009-12-31 Buy 0.01%$28.07 - $31.62
($30.04)
$ 71.80139%New holding11,700
XLVBill Gates 2009-06-30 Sold Out -4.19%$23.76 - $26.53
($25.04)
$ 71.80187%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

XLV is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


XLV: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Caplan, ElinorDirector 2015-08-28Buy8,000$0.88875view
Bunka, ChristopherDirector, Senior Officer 2015-08-28Buy10,000$0.1937689.47view
Bunka, ChristopherDirector, Senior Officer 2015-08-28Buy39,000$0.1937689.47view
Halcrow, DavidSenior Officer 2015-08-28Buy1,000$21.38235.83view
Busseri, Tony PDirector 2015-08-28Buy34,000$0.05143500view
Keough, Leni Edna FlorenceDirector, Senior Officer 2015-08-28Buy10,000$0.0979677.78view
Allibhai, Abdul RahimSenior Officer 2015-08-28Buy6,500$0.171700view
Batalha, Christopher RossSenior Officer 2015-08-28Buy86,500$0.323833.33view
Eskelund-Hansen, JensDirector, Senior Officer 2015-08-28Buy40,000$0.04179400view
MacLennan, AlistairDirector, Senior Officer 2015-08-28Buy100,000$0.01717900view

Quarterly/Annual Reports about XLV:

    News about XLV:

    Articles On GuruFocus.com
    S&P 500 Sector ETFs: A Look Under the Hood, Part 3 Mar 11 2015 
    Build a “Whatever Happens” Portfolio – Now! Aug 15 2014 
    Are Earnings Important? These Days, Revenues Count for More! Mar 17 2014 

    More From Other Websites
    AstraZeneca’s Profitability for 2Q15 Aug 28 2015
    Cholesterol drug wars Aug 27 2015
    Best way to play the market Aug 27 2015
    Ochsner's Rise After Katrina Aug 27 2015
    Pisani's market open: All 30 Dow stocks higher Aug 27 2015
    We are entering a bear market: Pro Aug 26 2015
    Worst is over: Tom Lee Aug 25 2015
    Short-Sellers Win Even With One Hand Tied Behind Their Backs Aug 25 2015
    An Analysis of AstraZeneca’s Growth Rate Aug 25 2015
    Market's big sell-off Aug 21 2015
    Pfizer’s Revised Financial Guidance for 2015 Aug 18 2015
    Fast Money Final Trade: Oil, S&P, banks & healthcare Aug 18 2015
    What’s in Pfizer’s Product Pipeline? Aug 16 2015
    Pfizer’s Revenue Falls by 7% in 2Q15 Aug 14 2015
    (Podcast) The $700 Million Man Who Lost His Fortune Aug 14 2015
    Pfizer Products with Negative 2Q15 Growth Aug 13 2015
    What Contributed to Pfizer’s Growth in 2Q15? Aug 13 2015
    The Spark: FDA approves first 3-D printed drugs Aug 13 2015
    Pfizer’s Improving Growth Rate in 2Q15 Aug 12 2015
    Pfizer Stock Rises on Positive 2Q15 Earnings Results Aug 12 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK